Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.

Nieves Martínez-LagoAna Fernández-MontesMarta CovelaElena M BrozosJuan De la CámaraJosé C Méndez MéndezMónica Jorge-FernándezAntía Cousillas CastiñeirasCristina ReboredoDavid Arias RonMaría L Pellón AugustoPaula González VillarroelBegoña GrañaMercedes Salgado FernándezAlberto Carral MasedaFrancisca Vázquez RiveraSonia Candamio FolgarMargarita Reboredo Lópeznull null

Published in: BMC cancer (2021)

GIT-BRAF-2017-01.

Keyphrases

metastatic colorectal cancer
wild type
oxidative stress
type diabetes
adipose tissue
replacement therapy
insulin resistance
weight loss